Formulations of a somatostatin modulator
US11957674B2 · kind B2 · utility
0Cited by
16References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2022 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Jan 25, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.